MASTROIANNI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 1.676
AS - Asia 683
EU - Europa 399
SA - Sud America 129
AF - Africa 16
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.906
Nazione #
US - Stati Uniti d'America 1.649
SG - Singapore 336
CN - Cina 109
BR - Brasile 106
RU - Federazione Russa 102
VN - Vietnam 76
HK - Hong Kong 74
IT - Italia 72
DE - Germania 57
IE - Irlanda 32
GB - Regno Unito 29
JP - Giappone 29
FR - Francia 16
MX - Messico 16
FI - Finlandia 15
NL - Olanda 15
IN - India 13
SE - Svezia 11
AT - Austria 10
BD - Bangladesh 10
AR - Argentina 8
CA - Canada 8
CZ - Repubblica Ceca 8
PL - Polonia 8
LT - Lituania 7
TR - Turchia 7
ZA - Sudafrica 7
EC - Ecuador 5
UA - Ucraina 5
ES - Italia 4
MA - Marocco 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
ID - Indonesia 3
JO - Giordania 3
UZ - Uzbekistan 3
VE - Venezuela 3
AU - Australia 2
BE - Belgio 2
EG - Egitto 2
IL - Israele 2
IQ - Iraq 2
IR - Iran 2
KR - Corea 2
PK - Pakistan 2
PY - Paraguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
HN - Honduras 1
HR - Croazia 1
KE - Kenya 1
KG - Kirghizistan 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 2.906
Città #
Wilmington 440
Houston 278
Singapore 215
San Jose 84
Woodbridge 81
Ashburn 78
Hong Kong 73
Chandler 59
Fairfield 58
Beijing 52
New York 35
Santa Clara 32
Los Angeles 31
Ho Chi Minh City 30
Tokyo 29
Rome 28
The Dalles 23
Seattle 22
Cambridge 21
Dublin 20
Hanoi 20
Munich 20
Ann Arbor 17
Nuremberg 16
Moscow 15
São Paulo 14
Buffalo 13
Council Bluffs 13
Dearborn 11
Denver 11
Helsinki 11
Medford 11
Orem 10
Boardman 9
Amsterdam 8
Atlanta 8
Dallas 8
London 8
Brooklyn 7
Johannesburg 7
Montreal 7
Warsaw 7
Brno 6
Da Nang 6
Mexico City 6
Vienna 6
Lauterbourg 5
Lawrence 5
Manchester 5
Phoenix 5
Redondo Beach 5
Stockholm 5
Suzhou 5
Chennai 4
Engelhard 4
Frankfurt am Main 4
Palo Alto 4
San Francisco 4
Amman 3
Chicago 3
Colorado Springs 3
Guangzhou 3
Jacksonville 3
Mumbai 3
Nanjing 3
North Bergen 3
Palermo 3
Ribeirão Preto 3
Salvador 3
San Diego 3
Tashkent 3
Anápolis 2
Belo Horizonte 2
Brussels 2
Campo Bom 2
Elk Grove Village 2
Florence 2
Fortaleza 2
Guayaquil 2
Hounslow 2
Hải Dương 2
Itapemirim 2
Jakarta 2
Lappeenranta 2
Leeds 2
Messina 2
Miami 2
Milan 2
Mislata 2
Mt. Dora 2
North Hollywood 2
North Shields 2
Olomouc 2
Paris 2
Pelotas 2
Pisa 2
Pontedera 2
Querétaro 2
Quận Bình Thạnh 2
Rio de Janeiro 2
Totale 2.116
Nome #
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14 371
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 333
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 297
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir± ribavirin in HIV/HCV co-infected patients 296
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection 249
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 99
Advances in Transcatheter Aortic Valve Therapy in Bicuspid Aortic Valve Disease: Insight into Patient Selection, Management, and Future Directions 90
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 90
Discontinuation of initial antiretroviral therapy in clinical practice : Moving toward individualized therapy 89
Brief Report: Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 88
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 87
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 87
Factors influencing place of death and disenrollment among patients receiving specialist palliative care 84
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 83
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50~cp/mL 80
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Na{\"i}ve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004?2014 79
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 74
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 73
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 67
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 64
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view 61
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 61
The Wounded Healer: A Phenomenological Study on Hospital Nurses Who Contracted COVID-19 57
null 20
Totale 2.979
Categoria #
all - tutte 10.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.203


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 7 4 4
2021/202269 1 5 3 3 7 3 7 4 12 5 5 14
2022/2023129 5 10 16 10 17 23 12 15 7 7 4 3
2023/2024145 16 5 3 1 9 19 0 4 6 59 1 22
2024/2025637 17 128 63 36 20 71 77 21 60 44 47 53
2025/2026995 93 57 100 127 134 50 129 123 119 63 0 0
Totale 2.979